| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1404351A4 Carbohydrate modifying agent and drinks containing the modifying agent |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1351942B1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 07/21/2004 | EP1331001B1 Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP1257260B1 Powder formulation for inhalation |
| 07/21/2004 | EP1228029B1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1131316B1 Improved chemical process and pharmaceutical formulation |
| 07/21/2004 | EP1124561B1 Compositions comprising a mixture of bioflavonols |
| 07/21/2004 | EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 07/21/2004 | EP1077694B1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 07/21/2004 | EP1067941B1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 07/21/2004 | EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors |
| 07/21/2004 | EP1007009B1 A pharmaceutical composition having two coating layers |
| 07/21/2004 | EP1005862B1 The use of tea polyphenols for the preparation of anti-chlamydia agents |
| 07/21/2004 | EP0999843B1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 07/21/2004 | EP0975604B1 Pyridazinones as inhibitors of cyclooxygenase-2 |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | EP0956024B1 Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen |
| 07/21/2004 | EP0941074B1 Delayed delivery system for acid-sensitive drugs |
| 07/21/2004 | EP0937040B1 N-substituted 2-cyanopyrrolidines |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | EP0910353B1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | EP0643775B1 Quinone derivatives for enhancing cellular bioenergy |
| 07/21/2004 | CN1514839A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
| 07/21/2004 | CN1514838A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
| 07/21/2004 | CN1514837A 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds |
| 07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 07/21/2004 | CN1514834A Cyclohexylphenyl vasopression agonists |
| 07/21/2004 | CN1514833A Novel tyrosine kinase inhibitors |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514825A New compounds useful in reflux disease |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1514822A Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
| 07/21/2004 | CN1514730A Excretion accelerator for accumulative chlorine compound |
| 07/21/2004 | CN1514729A Sustained-release analgesic compounds |
| 07/21/2004 | CN1514728A Nicotine-containing film preparation |
| 07/21/2004 | CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer |
| 07/21/2004 | CN1514726A Pharmaceutical compositions |
| 07/21/2004 | CN1514725A Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 07/21/2004 | CN1514724A Parasiticides for farmed fish |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1514722A Controlled release dosage forms using acrylic polymer, and process for making |
| 07/21/2004 | CN1514721A Once-a-day oxycodone for mulations |
| 07/21/2004 | CN1514720A Self emulsifying lipid matrix (SELM) |
| 07/21/2004 | CN1514719A Method of forming aerosol for inhalation delivery |
| 07/21/2004 | CN1514716A Breath protection microcapsules |
| 07/21/2004 | CN1514712A Nial Compositions and methods of administering same |
| 07/21/2004 | CN1513999A New earthworm kinase gene mutant |
| 07/21/2004 | CN1513973A Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 07/21/2004 | CN1513882A Preparation of carboxymethyl chitin bismuth and its application in treating gastritis and gastrelcoma |
| 07/21/2004 | CN1513881A Lucid ganoderma spore powder polysaccharide, production method and use |
| 07/21/2004 | CN1513879A Germanium enriced gold needle mushroom polysaccharide and its making metehod and use |
| 07/21/2004 | CN1513867A Antisense nucleic acid having inhibiting leukemid cell telomerase activity and its application |
| 07/21/2004 | CN1513866A mRNA antisense nucleic acid with inhibited VEGF expression and its application |
| 07/21/2004 | CN1513863A Dieneacetal peroxide glycoside kind derivative and its preparation method and its medicinal composition and use |
| 07/21/2004 | CN1513862A Preparation process of plantago fotal glycocide and its application in medicine |
| 07/21/2004 | CN1513861A Ibuprofen sugar conjugated product and its preparation method and application |
| 07/21/2004 | CN1513852A Plant extract and its application |
| 07/21/2004 | CN1513850A Rhodoalkane kind compound, synthesis method and its use |
| 07/21/2004 | CN1513848A Method of extracting phenolic components from chinese medicine red sage root and its freeze dried powder injection agent |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513839A Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation |
| 07/21/2004 | CN1513837A Clausend wanpi acidamine C5 hydroxy derivative and N substituted derivative, its preparation method and its medicinal composition and use |
| 07/21/2004 | CN1513832A Propanol amine kind ether compound synthesized using paeonol as mather body and its derivative |
| 07/21/2004 | CN1513831A Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative |
| 07/21/2004 | CN1513828A P-benzoquinone compound and its preparation method and use |
| 07/21/2004 | CN1513557A Compound cortex steroid medicinal composition |
| 07/21/2004 | CN1513541A Compound ginkgo leaf reparation and its making method |
| 07/21/2004 | CN1513518A Medicine for treating acute chronic bronchitis and its preparation method |
| 07/21/2004 | CN1513471A Injection of low molecular weight chondroitin sulfate and its prepn. method |
| 07/21/2004 | CN1513470A Health-care food with sobering function |
| 07/21/2004 | CN1513469A Regulatary factor T for cell growth, and its prepn. method |
| 07/21/2004 | CN1513468A Compound medicine of sodium citicoline and disodium cytidine triphosphate |
| 07/21/2004 | CN1513467A Small pellet of extraction of kudzu vine, and its prepn. method |
| 07/21/2004 | CN1513466A Small pellet of Erigeron breviscapus |
| 07/21/2004 | CN1513465A Method for preparing oral prepn. contg. total flavone of kudzu vine nd said oral prepn. |
| 07/21/2004 | CN1513464A Injection of invermection for treating ox-warble myiosis |
| 07/21/2004 | CN1513463A Application of timosaponin A3 for preparing medicine for treating No.2 type diabetes mellitus |
| 07/21/2004 | CN1513462A Intravenous inject contg. pseudo-ginseng total saponin and its prodn. method |
| 07/21/2004 | CN1513461A Feeze-dried powder injection contg. tatol saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodn. process |
| 07/21/2004 | CN1513460A Spreader cong. compound Triamcinolone acetate, and its prepn. method |
| 07/21/2004 | CN1513459A Freeze-dried powder injection contg. metallic complex of ethylenediamine teramethylene phosphoric acid, and its prepn. method |
| 07/21/2004 | CN1513458A Compound silver zinc sulfapyrimidine ointment, and its prepn. method |
| 07/21/2004 | CN1513457A Anti beta-bactamase antibiotic compound prepn. |
| 07/21/2004 | CN1513456A Eye drop contg. pazoxacin methanesulphonate, its prepn. method and its anti-infective function |
| 07/21/2004 | CN1513455A prepn. for stopping vomitus contg. compound pentoxifylline |
| 07/21/2004 | CN1513454A Dispersion tablet of vasilowy hydrochlaride and its prepn. method |
| 07/21/2004 | CN1513453A Controlled release tablet contg. pentoxifylline |
| 07/21/2004 | CN1513452A Use of CGMP phosphodiesterase inhibitor for treating sexual impotence |